A detailed history of Kendall Capital Management transactions in Organon & Co. stock. As of the latest transaction made, Kendall Capital Management holds 55,520 shares of OGN stock, worth $834,465. This represents 0.34% of its overall portfolio holdings.

Number of Shares
55,520
Previous 51,905 6.96%
Holding current value
$834,465
Previous $1.07 Million 1.12%
% of portfolio
0.34%
Previous 0.37%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$18.65 - $23.03 $67,419 - $83,253
3,615 Added 6.96%
55,520 $1.06 Million
Q2 2024

Aug 12, 2024

BUY
$17.45 - $21.96 $156,439 - $196,871
8,965 Added 20.88%
51,905 $1.07 Million
Q1 2024

May 10, 2024

BUY
$13.78 - $18.8 $72,069 - $98,324
5,230 Added 13.87%
42,940 $807,000
Q4 2023

Jan 26, 2024

BUY
$10.95 - $17.32 $159,267 - $251,919
14,545 Added 62.79%
37,710 $543,000
Q3 2023

Oct 31, 2023

BUY
$16.59 - $23.77 $73,792 - $105,728
4,448 Added 23.76%
23,165 $402,000
Q2 2023

Jul 28, 2023

SELL
$19.27 - $24.63 $32,373 - $41,378
-1,680 Reduced 8.24%
18,717 $390,000
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $40,162 - $60,150
1,875 Added 10.12%
20,397 $480,000
Q4 2022

Jan 30, 2023

BUY
$23.31 - $28.61 $42,890 - $52,642
1,840 Added 11.03%
18,522 $517,000
Q3 2022

Nov 02, 2022

BUY
$23.4 - $34.25 $84,825 - $124,156
3,625 Added 27.76%
16,682 $390,000
Q2 2022

Jul 29, 2022

BUY
$31.66 - $38.9 $103,623 - $127,319
3,273 Added 33.45%
13,057 $441,000
Q1 2022

May 06, 2022

BUY
$30.45 - $39.36 $297,922 - $385,098
9,784 New
9,784 $342,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Kendall Capital Management Portfolio

Follow Kendall Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.